Extracapsular dissection (ECD) has become an accepted, less invasive alternative for the removal of select benign parotid lesions that may reduce complications. Minimal margin extracapsular dissection (MECD) with dissection on or closer to the tumor capsule may be a reasonable alternative to ECD. The objective of this study is to review the complications and safety of the MECD technique at a single institution.
Subjects and Methods:
Medical records for patients who underwent MECD for suspected benign parotid lesions were reviewed. Outcome measurements included intraoperative findings, complications, and recurrences.
Results:
Forty patients underwent a MECD for suspected benign parotid lesions. The average tumor size was 2.2 cm. Frozen section revealed low-intermediate grade mucoepidermoid carcinoma in 2 (5%) cases, requiring completion of a superficial parotidectomy at the same setting. There was 1 case of temporary facial nerve weakness and no cases of Frey syndrome. No tumor recurrences were observed within the follow-up period (average 3.5 years.)
Conclusion:
In the hands of an experienced surgeon, MECD may be a viable alternative to formal superficial parotidectomy. This study reports low rates of nerve weakness and Frey syndrome. Long-term follow-up is necessary to determine the ultimate risk of recurrence.
SpiroRH. Salivary neoplasms: overview of a 35-year experience with 2,807 patients. Head Neck Surg1986;8:177-184.
2.
DonovanDTConleyJJ. Capsular significance in parotid tumor surgery: reality and myths of lateral lobectomy. Laryngoscope. 1984;94:324-329.
3.
KlintworthNZenkJKochMIroH. Postoperative complications after extracapsular dissection of benign parotid lesions with particular reference to facial nerve function. Laryngoscope. 2010;120:484-490.
4.
RawsonAJHowardJMRoysterHPHornRCJr.Tumors of the salivary glands; a clinicopathological study of 160 cases. Cancer. 1950;3:445-458.
5.
BenedictEGMeigsJ.V. Tumors of the Parotid Gland. A Study of 225 Cases with Complete End-Results in 80 Cases. . Surg Gyncol Obstet. 1930;51:626-647.
6.
McFarlandJ. Three Hundred Mixed Tumors of the Salivary Glands of Which 69 Recurred. Surg Gyncol Obstet. 1936;63:457-468.
7.
NaeimFForsbergMIWaismanJCoulsonWF. Mixed tumors of the salivary glands. Growth pattern and recurrence. Arch Pathol Lab Med. 1976;100:271-275.
8.
PateyDHThackrayAC. The treatment of parotid tumours in the light of a pathological study of parotidectomy material. Br J Surg. 1958;45:477-487.
9.
Guntinas-LichiusOKickCKlussmannJPJungehuelsingMStennertE. Pleomorphic adenoma of the parotid gland: a 13-year experience of consequent management by lateral or total parotidectomy. Eur Arch Otorhinolaryngol. 2004;261:143-146.
10.
LaccourreyeHLaccourreyeOCauchoisRJouffreVMenardMBrasnuD. Total conservative parotidectomy for primary benign pleomorphic adenoma of the parotid gland: a 25-year experience with 229 patients. Laryngoscope. 1994;104:1487-1494.
11.
WittRL. Minimally invasive surgery for parotid pleomorphic adenoma. Ear Nose Throat J. 2005;84:308, 310-301.
12.
YamashitaTTomodaKKumazawaT. The usefulness of partial parotidectomy for benign parotid gland tumors. A retrospective study of 306 cases. Acta Otolaryngol Suppl. 1993;500:113-116.
13.
LawsonHH. Capsular penetration and perforation in pleomorphic adenoma of the parotid salivary gland. Br J Surg. 1989;76:594-596.
14.
McGregorADBurgoyneMTanKC. Recurrent pleomorphic salivary adenoma–the relevance of age at first presentation. Br J Plast Surg. 1988;41:177-181.
15.
McGurkMRenehanAGleaveENHancockBD. Clinical significance of the tumour capsule in the treatment of parotid pleomorphic adenomas. Br J Surg. 1996;83:1747-1749.
16.
HancockBD. Pleomorphic adenomas of the parotid: removal without rupture. Ann R Coll Surg Engl. 1987;69:293-295.
17.
NatvigKSobergR. Relationship of intraoperative rupture of pleomorphic adenomas to recurrence: an 11-25 year follow-up study. Head Neck. 1994;16:213-217.
18.
WittRL. The significance of the margin in parotid surgery for pleomorphic adenoma. Laryngoscope. 2002;112:2141-2154.
19.
HancockBD. Clinically benign parotid tumours: local dissection as an alternative to superficial parotidectomy in selected cases. Ann R Coll Surg Engl. 1999;81:299-301.
20.
HenrikssonGWestrinKMCarlsooBSilfverswardC. Recurrent primary pleomorphic adenomas of salivary gland origin: intrasurgical rupture, histopathologic features, and pseudopodia. Cancer. 1998;82:617-620.
21.
BuchmanCStringerSPMendenhallWMParsonsJTJordanJRCassisiNJ. Pleomorphic adenoma: effect of tumor spill and inadequate resection on tumor recurrence. Laryngoscope. 1994;104:1231-1234.
22.
AlbergottiWGNguyenSAZenkJGillespieMB. Extracapsular dissection for benign parotid tumors: a meta-analysis. Laryngoscope. 2012;122:1954-1960.
23.
McGurkMThomasBLRenehanAG. Extracapsular dissection for clinically benign parotid lumps: reduced morbidity without oncological compromise. Br J Cancer. 2003;89:1610-1613.
24.
AsalKKoybasiogluAInalESternocleidomastoid muscle flap reconstruction during parotidectomy to prevent Frey’s syndrome and facial contour deformity. Ear Nose Throat J. 2005;84:173-176.
25.
TeknosTNNussenbaumBBradfordCRPrinceMEEl-KashlanHChepehaDB. Reconstruction of complex parotidectomy defects using the lateral arm free tissue transfer. Otolaryngol Head Neck Surg. 2003;129:183-191.
26.
SachsmanSMRiceDH. Use of AlloDerm implant to improve cosmesis after parotidectomy. Ear Nose Throat J. 2007;86:512-513.
27.
GiannoneNLo MuzioLPolitiM. Extracapsular lumpectomy and SMAS flap for benign parotid tumours: an early outcome in a small number of cases on Frey’s syndrome and facial nerve dysfunction. J Craniomaxillofac Surg. 2008;36:239-243.
28.
RappaportIAllisonGR. Superficial musculoaponeurotic system amelioration of parotidectomy defects. Ann Plast Surg. 1985;14:315-323.
29.
Dell’Aversana OrabonaGBonavolontaPIaconettaGForteRCalifanoL. Surgical management of benign tumors of the parotid gland: extracapsular dissection versus superficial parotidectomy—our experience in 232 cases. J Oral Maxillofac Surg. 2013;71:410-413.
30.
PiekarskiJNejcDSzymczakWWronskiKJeziorskiA. Results of extracapsular dissection of pleomorphic adenoma of parotid gland. J Oral Maxillofac Surg. 2004;62:1198-1202.
31.
DalleraPMarchettiCCampobassiA. Local capsular dissection of parotid pleomorphic adenomas. Int J Oral Maxillofac Surg. 1993;22:154-157.
32.
WardCM. Injury of the facial nerve during surgery of the parotid gland. Br J Surg. 1975;62:401-403.
33.
LanierVCJrMcSwainBRosenfeldL. Mixed tumors of salivary glands: a 44 year study. South Med J. 1972;65:1485-1488.
34.
ZbarAPHillADSheringSGA 25 year review of parotid surgery. Ir Med J. 1997;90:228-230.
35.
CarewJFSpiroRHSinghBShahJP. Treatment of recurrent pleomorphic adenomas of the parotid gland. Otolaryngol Head Neck Surg. 1999;121:539-542.
36.
MaimarisCVBallMJ. Treatment of parotid gland tumours by conservative parotidectomy. Br J Surg. 1986;73:897.
37.
McEvedyMVRossWM. The treatment of mixed parotid tumours by enucleation and radiotherapy. Br J Surg. 1976;63:341-342.
38.
ArmitsteadPRSmiddyFGFrankHG. Simple enucleation and radiotherapy in the treatment of the pleomorphic salivary adenoma of the parotid gland. Br J Surg. 1979;66:716-717.
LaskawiRSchottTSchroderM. Recurrent pleomorphic adenomas of the parotid gland: clinical evaluation and long-term follow-up. Br J Oral Maxillofac Surg. 1998;36:48-51.
41.
FeeWEJrGoffinetDRCalcaterraTC. Recurrent mixed tumors of the parotid gland—results of surgical therapy. Laryngoscope. 1978;88:265-273.
42.
NiparkoJKBeauchampMLKrauseCJBakerSRWorkWP. Surgical treatment of recurrent pleomorphic adenoma of the parotid gland. Arch Otolaryngol Head Neck Surg. 1986;112:1180-1184.
43.
PatelNPooleA. Recurrent benign parotid tumours: the lesson not learnt yet?Aust N Z J Surg. 1998;68:562-564.
44.
PhillipsPPOlsenKD. Recurrent pleomorphic adenoma of the parotid gland: report of 126 cases and a review of the literature. Ann Otol Rhinol Laryngol. 1995;104:100-104.
45.
RenehanAGleaveENMcGurkM. An analysis of the treatment of 114 patients with recurrent pleomorphic adenomas of the parotid gland. Am J Surg. 1996;172:710-714.
46.
LeversteinHTiwariRMSnowGBvan der WalJEvan der WaalI. The surgical management of recurrent or residual pleomorphic adenomas of the parotid gland. Analysis and results in 40 patients. Eur Arch Otorhinolaryngol. 1997;254:313-317.
47.
LinderTEHuberASchmidS. Frey’s syndrome after parotidectomy: a retrospective and prospective analysis. Laryngoscope. 1997;107:1496-1501.
